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Biostatistical Issues in the Design and
Analysis of Multiple or Repeated
Genotoxicity Assays
byLutz Edler
Testsforgenotonicormutagenic effectsofchemicalshavepromptedefficientbiostatistical methodsforthequantification
ofdose-response data,especiallyfromtheAmesSalmonella/microsome assay. Adecisionaboutthegenotoxicityofacom-
pound is, however, always based on several assays, and results frommultipleorrepeatedgenotoxicity assays have to be
combined eitherqualitatively or, even better, quantitatively. Thelatterproblemisconsideredhere, andissuesfordesign
and analysis are addressed. General recommendations for designing genotoxicity assays are given. A long-known
methodologyforcombiningquantitative parametersfromdifferentexperimentsisupdatedandotherstatisticalmethods
suitable forthecombinedanalysesofmultipleassaysare presented. Someaspectsofdesignandanalysis areelucidated
on count data from unscheduled DNAsynthesis assays.
Introduction
The increasing number of chemicals, their spread into the
human environment, and their consumption by humans urges
quantitative evaluations oftheirpotential adverseeffects. Forthis
reason, short-term tests (STT) have become a widespread
biological assay for detecting and assessing genotoxic and
mutagenic effects. Growing awarenessofgenetic factors related
to humandiseases andtheidentification ofproto-oncogenes and
tumor-suppressor genes have sparked renewed interest in the
mechanisms ofgenotoxicity ofenvironmental agents.
Biostatistics has contributed to the design and analysis of
genotoxicity assays in important fields: Trend tests have been
developed totestforthe presence orabsenceofgenotoxic effects,
and they superseded multiple pairwisetesting. Nonparametric
methods replacedparametric ones, suspendingtheassumption
ofaGaussian normal distribution. Transformations were used
todeal with varianceheterogeneity. Weightedregressions were
applied for fitting dose-response models that had been estab-
lishedeither asempirical statistical models or asstructural math-
ematical models motivated by biological considerations.
Methods forcoping withoverdisperseddataandtests forcheck-
ing the distributions ofthedata weredeveloped. Outlier detec-
tion and use ofhistorical control information have been estab-
lished for quality control. Methods for the analysis of a single
assay havebeen summarizedrecently (1). Therehavealsobeen
suggestions and improvements for the design ofgenotoxicity
assays [Seetheguidelines oftheUnitedKingdom Environmental
Biostatistics, German Cancer Research Center, Im Neuenheimer Feld 280,
D-6900 Heidelberg, Germany.
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MutagenSociety (UKEMS)1(2). Thesearemostlyintuitiveand
empiricallyprovedmethodsratherthantheoriesandthey maybe
called "statistical common sense."
In practice, genetic toxicologists do not conduct only one
single assay. Usually, they repeat an assay several times either
underidenticalorvaryingconditions. Thismaybedonetoassure
previous results or to cope with the fact that genotoxicity ofa
compoundcanbeexpressedindifferentways. TheAmestest, for
example, has used several tester strains sensitive to different
types of mutations. Thus, results from multiple or repeated
genotoxicity assays have to be combined somehow. Decision
makingonthepresenceorabsenceofgenotoxicity is supported
formally by statistical methods ofmultiple comparisons, and
theremaybefurtherprogressby useofBayesmethods. Onthe
otherhand, thereisalsoneedforaquantitativecombinationof
results fromseveral assays. Linearmodelsand, more recently,
generalizedlinearmodels(GLIMs) canbeusedifthedesignof
theexperimentwasregularenough. Inothercases, long-known
methodsofweightedmeansareuseful. Theiruseforgenotoxicity
assayswillbedescribedbelow. Beforedealingwiththequestion
ofhowtocombineestimates, somegeneraldesignconsiderations
forgenotoxicity assays aregiven.
Design and Conduct of
GenotoxicityAssays
This section addresses and illustrates basic elements of ex-
perimentaldesign. Moredetailsonvariousassays(bacterialand
mammalian cell colony and fluctuation, in vitro and in vivo
chromosomalaberration, sisterchromatidexchange, Drosophila
and dominant lethal) can be found in Kirkland (2). Basic
biostatisticalelements indesigninggenotoxicity assaysarelisted
inTable 1. StatisticalanalysisrequiresthespecificationofanendL. EDLER
Example
Cell, cell culture inpetridish, animal in vwvo
assay
Observability, measurability, identifiability
Inoculum size, parallel survival assay, in-
cubationpriortotreatment, treatmentinnon-
nutrient medium, treatment after growth in
nutrient medium.
Two-sample, many-to-one sample, dose
response, controls
Sources ofbias
Methods ofstatistical evaluation
point, whichmightbe afrequencyofcounts, amutation rate, etc.
Questionsofobservability, measurability, andidentifiabilityhave
tobeaddressedin some cases, e.g., when amutationratehas to
becalculated from amutation and aparallel survival assay. The
numberofcells seeded on aplate (inoculum size) orother con-
ditions ofexperimentation affectthe outcome. Therecognition
ofsourcesofvariability isimportant. Wedistinguishwithin-assay
variability andbetween-assayvariability. Within-assayvariabili-
ty contributes to the sampling variation and may be caused by
dilution, weighing, pipetting errors, variability inexperimental
handling, variabilityofcelldivision rates indifferentplates, or
counting errors. Between-assay variability contributes to repro-
ducibility and may becausedby physical andchemical proper-
ties of the agents, their storage and preparation, or changing
growth conditions. Moregeneralbetween-assay variability may
becausedby "historical" changes oftheprotocol, bypersonnel
fluctuation inthe staffofthe laboratory, orby agenetic driftof
the biological material.
A second important aspect is statistical bias: a systematic
changeoftheendpointvariable, usually tohigher orlowervalues
thanexpectedundertheidealexperimental conditions. Thereis
no guaranteed protection against biases, but there are
possibilities toreduce oratleastrecognizethemby somelessons
learned from clinical-trials methodology: Running assays in
severallaboratories(multicentricity) increasesthetestingcapaci-
ty, allows the assessmentofinterlaboratory variability, and in-
creases representativity ofthe result. Blindevaluationispossible
byusingcodedchemicalsandcodeddose groups, andrandom-
izationbetween laboratories andoftheorderofexperimentation
might be possible.
Experimentation
Formal experimental requirements have to deal with repro-
ducibility: Physical andchemicalpropertiesoftestcompounds
have tobe well characterized andcontrolled. Agenetic driftof
the biological material during prolonged culturing has to be
recognized early. Induction, preparation, and storage ofcom-
pounds and solvents is amajortechnical point. Decisions have
to bemade, forexample, between agar-based andliquid-based
assays. Useofauxiliary exogenous metabolic activation(e.g., S9
mix inAmestest) orselectiveagents mustbeconsideredbecause
mosttargetcellshaveonlylimitedendogenous metaboliccapaci-
ty. The guarantee ofa stable and low spontaneous mutant fre-
quency becomes a majorpoint, when, at the same time, suffi-
cientnumbers ofcells have tobeplated toavoid zero counts. It
hasbeenrecommendedthatthenumberofcellsplatedinitially
shouldassurethatacomplete setofzerocountsoccurswithprob-
ability nothigherthan5% (3). Replicatedculturingisbasicfor
statistically evaluable repeated measurements, but a sound
statisticalestimationofvariabilityrequiresseparate, stableprep-
aration and treatment, notmerely splitting the samemixture.
Design
Factors that are a potential source of confounding include
numberofcellsatinoculation, numberofreplications, number
oftreatment/dose groups, interval ofdosing, andthechoiceof
controls. Mahonetal. (3) recommendaminimumofthreedose
levels and two separate cultures in each dose group. Blank
negative controls and solvent negativecontrols shouldbe used
(4). Positivecontrolsshouldbeincorporatedroutinely forquali-
tycontrol. Somegeneral requirementshavebeenlistedinTable
2. Importantelementsofstatistical designarerandomizationand
assessmentofresultsunderblindconditions. Theeffortandtime
spenttocheckfortheapplicationoftheseelementswillresultin
morereliableandreproducibleresults. Twobasicdesignscanbe
distinguished: (a)testingforadifferencebetweenthetreated(ex-
posed) andtheuntreatedcontrols, (b)establishmentofadose-
responserelationship withtheaimtoquantifygenotoxicpotency.
Anotherbenchmarkisthechoicebetweenparametricandnon-
parametricmodels. Althoughthiscanstillbedecidedwhenthe
experiment is over, it is wise to consider it in thedesign phase
becauseofitsimpactontheoptimaldeterminationofdosegroups
and the number ofreplicates perdose.
EndPointsandDataStructure
Thestructureofthedataofagenotoxicity experimentdepends
on the type ofthe experiment and on the experimental units.
Defining factors are shown in Table 3. Mostly, theend point is
either a count (e.g., count ofrevertants, count ofaberrations,
countofsisterchromatidexchanges), oritisaproportion, ifthe
countshavetoberelatedtoabaselinenumber(e.g., thenumber
ofsurvivingmutantsamongallsurvivors). Quantitativedataare
usually hierarchically structured by treatments (dose groups),
solvents, replicated cellcultures, andrepeated measurements,
takenatindividualcells. Furtherstagesontopofthishierarchy
may be different laboratories orothertargetcell strains.
¶Uble2. General requirements ofdesigningadose-response assay.
Blank and solvent negative controls
Positive control
Minimum ofthreedose levels
Minimum oftwocultures
Increased numberofreplicates forthe negativecontrols
Numberofreplicates perdosegroupdependonthe frequency ofzero counts:
Ames assay, 3-5; sisterchromatidexchange, about50;
chromosomal abberation, about 200
Table 1. Biostatistical elements in designing genotoxicity assays.
Element
Experimental unit
End point
Conditions for evaluation
Treatment groups
Sources ofvariability
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Table 3. Defining factors forthe data structure ofagenotoxicity assay.
Factor Examples
Agents Chemicals, radiation, viruses
Experiment In vitro, in vivo
Measured units Microbes, cells, cultures, insects/mammals
Design Treatment/control, dose response
Evaluative criteria Qualitative, quantitative
End points Counts, proportions
Sampling Model
The predominant question about sampling models has
centered aroundtheappropriateclassofstatisticaldistributions
fortheobserved countdata. This wastriggeredbytheobserva-
tion ofextra-Poisson variation in the Ames test. Concurrent to
methods coping with this so-calledoverdispersionis the useof
transformations toward normality ortheanalysis ofmeans ob-
tained from an appropriate large number ofmeasurements.
Dose-Response Model
The primary choice ofa dose-response model is between a
parametric and a nonparametric functional species. Nonpara-
metric methods maybepreferredifnoagreementonacommon
samplingmodelcanbefoundorifonelooksforstatistical models
thatare valid underdifferentexperimental conditions (laborato-
ry, tester strains, age, andstatusoftestcompound). Ontheother
hand, aparametric dose-response modelprovides aneasierway
to obtain mutagenic potency measures.
Control ofVariability
Weighing, pipetting, transferring microbialcellsbetweenves-
selsandplates, andclumpingofcellsarefactorsusually contrib-
utingtoahighvariability. Othersourcesarevaryingtoxicities on
plates, different ratesofcelldivision, dilutionorcountingerrors,
variable operators' skills, andcalendertime. Invvo experiments
arefurtherloadedbygeneticdifferencesbetweenanimals. Use
ofnegativeandpositivecontrols isgenerally advisedtocontrol
forday-to-day and animal-to-animal variability. Negative con-
trol data should lie in an acceptable range and should be com-
pared with historical control data. Ontheother hand, positive
control datashouldconfirmtheeffectivenessoftheentireassay.
Table4concernstheuseofcontrolinformation intheprocessof
deciding aboutgenotoxicity.
Table4. Elementsofdecisionmaking
Is there homogeneity betweennegative controls?
How do current negative controls compare with historical negative controls?
How do currentpositive controls compare with historical positive controls?
Dothetreatmentgroupsexceedthenegativecontrols oranabsolutethreshold?
Do the treatment groups show adose-response relationship?
Was there increasedtoxicity ordecreased cell survival?
Is there reproducibility between different cultures in the same experiment,
between different experiments in one laboratory, or between different
laboratories?
Multiple Experiments in Genotoxi-
cology: An Example
Multiplicity ofgenotoxicity assays is shownclearly inthe in-
vestigationsperformedbytheU.S. NationalToxicologyProgram
(5). Recently, 42 further chemicals were examined using the
AmesSalmonella testinfourlaboratories (upto3 perchemical),
with3 solvents (upto2perchemical), 5testerstrains, 3 S-9mix
categories (none, hamster, rat), andwithasmanyas4repetitions
per laboratory. This would have led to 1680 assays for one
chemicalifthemaximumnumberofpossiblecombinationshad
been used. Ofcourse, mostofthepossible combinations were
not realized because of a reduced number of laboratories, a
choicestrategy fortesterstrains, andthechoiceoftheS-9mixes
(andcosts). Infact, mostchemicalsaretestedinonelaboratory
andwith onechemical only, which reduces this number to 140
possible combinations. Actually, the total number of dose-
response experiments for a genotoxic investigation is usually
below 100. For tribromomethane (Bromoform), Zeiger (5)
reported 98 dose-response experiments. Reasons for multiple
experiments vary. Duplicates are run forconfirmation; random
inclusion ofknown positive and negative controls are used for
monitoringandcontrollingthequalityofthelaboratory; repeated
tests are run ifunexpected orconflicting results were obtained
(6). Table 5 gives the nomenclature forthe methods discussed
in the following section.
Combination of Estimates
Notethatbeforecombining results, ithastobeprovedthatthe
resultsaresuitabletobecombined. Thisisnoteasyandmaybe
only partially solvable by statistical tests on heterogeneity or
trend. Experimental comparability should be addressed in
cooperationwiththebiologist. Ontheotherhand, theremaybe
situations where one has to come to a conclusion based on a
seriesofestimatesifthereremaindoubts onthecomparability.
One Factorial SetofExperiments
Let us consider I assays where each has led to an effect
estimate, mi, with a variance estimate, vi, i = 1,..., I [see
Cochran (7)]. In somecases wealso assumethattheestimate vi
Table5. Nomenclature formultiplegenotoxicity assays.
Group Dose Measurements
Oneassay: dose-response experiment
Negative control
Solvent control
d0
Dose group
Dose group dI
Positive control
Multiple assays: morethan oneassay parallel
Repeated assays: multiple, nonparallel assays
X01..XOno
XI XI
01 .... On'o
xl ...xlI
n
. In,
xfP ....xi
Experiment: usually anextendedstudycomprising morethan one assay
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is based onfi degrees offreedom and isstochastically indepen-
dent of mi. An additive model for the estimate mi is assumed
Table 6. Unweighted andweighted means.
Type ofmean Equation
mi = m + (mi -m) + ei (1)
where m is the combined effect, ai = mi - m is the interassay
deviation, and e, is the intra-assay error. The variable aiand ej
are assumed to have expectation 0 and variances a2 and a,2.
E[ai] = 0 would imply thatthere is no interassayheterogenei-
ty. Notethatthiscorresponds to alinearmodelofcompletedata
ofthe form Y0, = m + ai + eij, where, for example, a, and eij
areindependentand standardnormally distributedwith expec-
tation 0andvariances a2 ando0, respectively. Special cases are
covariance analyses ofeither (a) Yej = m + ai + bidij + eij or (b)
Yxj = m + ai + bdj + ej. Caseb contains acombineddoseeffect, b,
which summarizes the singledoseeffectsbi from case a, ifthe
variances a2 do not dependent on the ith assay. Regression
within the groups (assays) leads to an estimate, b, which is a
weighted mean ofthe individual estimates, bi. Without further
assumptionsinEquation 1, weighted meansofdifferentdegrees
ofcomplexity canbecalculated. A systematic compilation was
given in Edler (8) see also Tarone et al. (9). The unweighted
meanistheunbiased, least-squareestimateofminimalvariance
as long as inter-and intra-assay variabilities, "2uandai2 areequal
to 0. Otherwise, a weighted mean estimate with weights
w; = /(aa2 + a? is atleastofminimal variance. Fourclasses of
means can be distinguished if ur2 and a: are unknown, as
discussed below.
UnweightedMean. Variances aregiven separately foru4=0
or .ai * 0 in Table 6. For the degrees offreedom see Cochran
(7).
Grand Mean. Weighting by the degrees of freedom of the
variances orby sample sizes, ni, givesthegrand mean(Table6).
Variance and degrees of freedom are obtained similar to the
unweighted mean.
Semiweighted Means. Use of weights, wi
= / of + a2, is
known as semiweighting (Table 6). The variance components,
aq2, will be estimated from the variances, vi . More difficult is
the estimation ofthecomponentaa2. Rao etal. (10) showed four
possible solutions, an ANOVA-type variance component
estimate, a modification circumventing negative variance com-
ponents, anunweighted sumsofsquares, and anMINQestimate.
Variance-weightedMeans. Ifu4 = 0, theweighting reduces
to wi = l/vi. Thenthisvariance-weighted meandepends heavi-
ly on experiments of high accuracy, and assays with a large
variancehavealmost noinfluence. Tocounteractthis, aso-called
partially weighted mean was introduced: The assays are sub-
divided into a class oflow-precision assays weighted by their
respective large variances and a class ofhigh-precision assays
weightedby ameanofthosesmallvariances. Notealsothedirect
correspondence of weighted means and methods of meta-
analysis, as well as their relation to Bayesian methods if the
choice of a weighting scheme can be related to the choice of a
prior distribution.
Multifactorial SetofAssays: Combination
ofGroups ofEstimates
Multiple assays areusually structuredby several factors, and
it often becomes necessary to combine estimates over someof
Unweighted mean Uw I= 1 i)
Interassay variability
Yes (d," > 0)
No (aq. = 0)
Grand mean
Interassay variability
Yes (ao > 0)
No (o2 = 0)
Semiweighted
Weights
if& > 0
if
= 0
I (I 1) m
1
I2EvI
mGrand = n (1X imi)
l =
=n(a2+wvi)
(I~ni)2
(Toni)2
mSW= W twimi
Var = 1
W
1
Wi =
. 2
cya + vi
1
w.
''l= Pi
Partially variance-weighted
Increasing orderofthe variances
Weights
Partial weight for small variances
W = jwi
if cs> 0
a
ifb
= 0
a
dVW
= W
v1 5V2 < ...*v 1/2 < *** VI
1
w. = 1
1 Vp
.-I/2
vp = I 2f
i = 1
w. = _ Wi 1V.
-( A.I/2
i =
Table 7. Combinationofgroupsofestimates.
Assays Ell, E12 . .-..........Ell
E21, E22. ............E212
ERI,Ein ...................EpR[
Withestimates m vi i = 1, Ir = 1, R
those. It might be reasonable to combine the estimates ofthe
Amestestassaysoverdifferentmetabolicactivationlevelswhen
thereisasmallnumberofrepeatedassaysavailableforeachac-
tivationlevel(Table7). Combiningthosegroupsofestimates can
beaccomplished stepwiseby estimating oneach stepthebasic
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parametersandtheirvariancesby asemiweightedmean.Inatwo-
stepapproach, oneusesatfirstthemodelmi = mr + ai + ej,
where mi denotes the mean effect ofthe rth group combined
over the repeated assays, aidenotes theinterassay deviations in
the rth group, and ei is theerrorterm. Inthis firststep, onecan
estimate themeansforeachgroupaswellastheirvariances. This
gives thegroupwise pairofestimatesMr, Vr. Thesecond step is
based on the model Mi = m + Ar + Er, where m is the com-
bined effect and Ar is the intergroup deviation. This second
linear model is then the basis for a final semi-weighted mean
MsW = (2WrMr)/Wwith W= Wrand Wr = 1/(SA + Vr),
whereSAdenotes anestimate ofthevariancecomponent. IfSo<
0, use of other weights or use the unweighted mean (9) is
suggested.
Problems arise ifthe number ofreplications is small. Thenan
adhoc solution would be aresampling method, wherefromeach
group one estimate is sampled randomly and the mean, m", of
those Ivalues is determined together with a variance estimate,
v". The random sampling can be repeated many times like a
bootstrap procedure. A total mean, mb, ofall repeatedly calcu-
lated means, m", would give the estimate ofthe grand effect. A
variance estimatecan beobtained as the sumofthe "bootstrap"
variance ofthe me around mb and a mean variance between the
I groups obtained as mean of the variances v". For details see
Edler (8).
Example: DNA Damage Repair
Short-Term Assays
Unscheduled DNA synthesis [UDS (11)] is a type of short-
term test that uses the fact that specific cells (e.g., human
fibroblasts) areable to synthesize DNAbeyond S-phase, between
phases GI and G2, (12). UV-induced synthesis ofDNA between
GI and G2 suggests repairofdamaged DNA. In fact, most cells
incorporate 3H-TdR into DNA duringall stages ofthe cell cycle
after damage. A distinction between S-phase and non-S-phase
isachievedbypreexposurelabeling, resulting inheavilylabeled
S-phase cells, and postexposure labeling, resulting in lightly
labeled non-S-phase cells representing UDS.
Theexperimental set up for an in vitro UDS assay may be as
follows (13): Cells are taken from living tissue, incubated, and
grown withantibiotics inmediumintissuecultureflasks. Growth
should be permitted untilconfluency toavoid replication nuclei,
with enormous 3H-TdR uptake. Next the cells are labeled with
3H-TdRtoobtain heavily labeled S-phasecells. Thenthey areex-
posedtothechemical carcinogens. They arelabeled again, and
autoradiograms aretakenafterwashing, fixing, anddryingthem.
Useofradioactively labeledthymidine allows theapplication of
autoradiography. The autoradiograms themselves require
developing, fixing, washing, drying, and stainingthespecimen.
This enables one to quantify the repair capacity of cells after
some exposure to damaging agents as well as the amount of
damage that is assumed to correspond to the amount ofrepair.
More experimental details were found by Cleaver (14), who
calculated mean numberofgraincountsoflabeledcellsadjusted
forbackground by subtracting ameanofgrain counts in fields of
equal size outside the cell nucleus.
Invivo UDS in rathepatocytes as complementary short-term
assay to the mouse bone marrow cytogenetic was described by
MargolinandRisko (15). They analyzedtheendpoints, sources
ofvariability, and the roleofhistorical controls.
Autoradiography
Tounderstand thevariabilityofthedataobtainedbyautoradio-
graphic methods, ashortdescriptionofthemethod is inorder.
Basically, autoradiography is a photographic method used to
determinethedistributionofradioactivity inaspecimencontain-
ing radioactivematerial. Duringautoradiography, the radioac-
tivespecimenisplacedincontactwithaphotographicemulsion
consisting of grains of silver halide, usually bromide. The
photographicemulsion issuspendedinagelatinmatrix, almost
always coated on a glass plate or a film ofcellulose acetate or
polyesterresin. Ionizingradiationliberateselectrons, whichin-
itiates a reduction ofsilver ions into metallic silver at the site
where radioactivity interacts with theemulsion. Photographic
developmentenhancestheeffectcatalytically, byreductionofad-
ditionalsilverionsintheimmediatevicinityofinteraction sites.
Unaffected silver ions are removed by a fixing solution. The
distributionofmetallic silvercorresponds tothedistributionof
radioactivity on the specimen. Experimental variations are
possible by type and duration of the contact between
photographicemulsionandradioactive specimen. Thusonemay
distinguish betweentemporaryandpermanentcontact, usingthe
sprinkling, slapping, dipping, floating, orstrippingtechniquefor
theestablishmentofthecontact(16). Theemulsionisfixedand
stainedaftersomeexposureanddevelopmenttime. Locationand
intensity ofradioactivity ofthe specimen is indicated by black
spotsorgrainsofmetallicsilver. Theendpointsoftheevaluation
are the silver grains made visible by this method and their
number per cell nucleus. These grains are evaluated micro-
scopically orbyimageanalysis. Thequantitativeendpointisthe
numberandtheareasofthegrains. Theselectionprocedure for
cell identification and counting per nucleus has tobe defined;
random selection is preferred and "blindness" should be
ensured.
Themain sourceofconfoundingisthebackgroundradioactiv-
ityandgrainsgeneratedbyothersourcesthantheexperimentally
controlled radioactivity. This may be the result ofprolonged
developmentoftheemulsion, exposuretodaylight, radiationef-
fectsfromlaboratoryenvironmentorcosmicradiation, pressure,
chemography, metal ions, static electricity, and differences in
theirconcentrationofsolublebromideions (17). Thepresence
ofbackground grains poses aproblemforthe analysis ofauto-
radiographic counts. In dose-response experiments, the
backgroundcanbesubsumedunderthecontrol group (dose =
0) aslong asbackgroundintensitydoes notdependonthedose
Ishikawaandhiscoworkers (18) usedforagraphicdisplayofa
plotofthemeannumberofgraincountsversusthelogarithmof
thedose. ThisconceptwasfurtherdevelopedinThielmannetal.
(13). Among several other transformations investigated, the
meanversuslog-dosegavequalitatively thebestresults. Plotting
the mean number ofgrain counts versus the logarithm ofthe
dose, a parameter, Go, describing the linear increase of the
meannumberofgrainsresultingfromadoseincreasebythefac-
torofe = 2.72 wasusedasthepotency. Thesimplelinearregres-
sionhastheadvantageofallowing astraightforwardevaluation
ofrepeatedexperiments. Anormaldistribution canbeassumed
becausealargenumberofcellscanbeevaluated. Aninvestigation
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of individual animal net grain counts for the in vivo UDS rat
hepatocytesassayrevealedthatmeannetgraincountsoftwoor
more animals may be considered as normally distributed (15).
Linear Regression Model forMean Counts
DataforaUDSdose-response assayarethenumberofgrain
counts, Yij per nucleusj (j = 1,...n,), and dose group i (i =
1,...1). The increase ofthe mean number ofgrain counts per
nucleus withdose is usually concave, suggestingalogarithmic
transformationofthedoseasdiscussedabove. Toxicityorsatura-
tioneffects, which arenotwellunderstood, maycauseadown-
turn of the dose-response curve at high doses. A recursive
step-downprocedure wasusedtocopewiththis. Letthemodel
yi = ax + ,B1ndi i = 1,1,.1
be given forthe mean numberofgrain counts, eventually after
subtraction ofthe mean ofthe zero dose group. Then the suc-
cessive regression equations
yj = ca + 01lndi i = 1, ,.I-
are evaluated for r = 0, 1,...1-3, and doses di arediscarded as
long as a selection criterion holds, such as the minimum
estimated standarderror (standarddeviationoftheresiduals). If
the procedure stops atR = R, the resulting model
yi= a + lndii = 1, 1,...,R
is evaluated by simple linear regression.
Another selectionprocedurecouldbebasedonthemethodof
Simpson and Margolin (19). The slope estimate $ is used as
measure of repair capabity. This simple linear model for the
mean number ofgrain counts perdose has, compared to more
complex adaptive procedures, the advantage that it allows a
straightforward evaluationofrepeatedevaluationsandrepeated
experimentsperday, severaldays, oreven severallaboratories.
Because variance homogeneity might not hold in general,
weightedregressionmethodsmaybeindicated. Notethatmean
counts, Yi, are nolongerindependent whenthezerodosemean,
Yo, hasbeensubtracted. However, thedifferences areindepen-
dentofYo, andhencetheestimationoftheslopeandtheerrorof
variance areunaffected.
Table & ResultsofUDS determination for 11 selected vohmteers from
the German xeroderma pigmentosum program.'
Strain Go Variance
S1 2.85 0.004
S2 2.36 0.13
S3 2.18 0.62
S4 3.35 0.57
S5 3.46 0.001
S6 2.43 0.31
S7 2.93 0.75
S8 4.09 0.79
S9 3.26 3.27
SlO 4.48 1.73
Sl1 3.09 4.41
UDS, unscheduled DNA synthesis.
'Govalues ofeach assay wereobtainedby linearregression and results oftwo
tothreeassays werecombinedby anunweighted meantoacommonGovalueof
each cell strain.
Deviationsfromdoselinearity areobservedfrequently. Asim-
pledevice is to use apiecewise linearregression, forexample,
bydistinguishing twodoseregions. Table8showstheunweighted
meansofanevaluationof11 selectedstrainsofvolunteersfrom
alarge-scaleevaluation(13). Slopeestimates, Go, hadbeenob-
tainedfromtwotothreedose-responseassaysbylinearregres-
sion as described above. Go for strains S1 and S5 had a high
precision in contrast to strains S9, Sil, and to some extentSlO,
whichhadalowprecisionbecauseofahighinterassayvariability.
Thesemiweighted meanovertheseunweightedmeansresulted
in a combined Go of 3.0 for all normal strains with variance
estimated as 0.07, whereas the partially weighted mean gave a
combined Go = 2.9 withvariance0.09. Withoutthethree low-
precision strains, we obtain a semiweighted mean of2.9 with
variance0.07 and apartial weighted meanof2.8 with variance
0.05. ThevariancecomponentwasestimatedbytheMINQpro-
cedure (10).
Dose-response experiments for the in vivo UDS assay were
analyzedbyMargolinandRisko(15)by asimplelinearregres-
sion, aslongasthedose-responsecurveshowed nodown-turn
athighdoses. Ifthere wassuchadownturn, asimplequadratic
regressionwasapplied. Inbothcasesameasureofmutagenici-
ty was calculated from the estimated regressionparameters.
Alternative Methods for UDS CountData
Anonlinearregression modelE[Yij = zi(xi, 1) = c1X (xi, 1)
can be applied if u or X can be specified as a structural dose-
response relationship. The covariatexi is able to contain ar-
bitrary factorinformation, i.e., datafromrathergeneraldesigns
canbeanalyzedthis way. Ifitcanbe shown thatthecountdata
Yij follow a Poisson distribution, Poisson regression methods
canbeapplied(20). Ifthedependenceofthecovariatecanbeex-
pressed via a link function, the solution is also obtained by
generalized linearmodels(GLIMs).
Engel(21)appliedquasi-likelihoodmethodstotheanalysisof
countdatafromnesteddesigns. Thelog-quasi-likelihood 1(ux)
satisfiestheequationallay = (x - s) X V(y)whereV(i) isthe
variancefunction. Tvotypesofmeanvariancerelationshipshave
beenfoundtobeimportantforcountdata: V(jy) =augor V(y)
= a2i2. Adesign wherearandom factor, B, is nested within a
secondrandomfactor,A, wasconsideredaswellasadesignwith
twofixedfactors, AandB,fordata Yij, i = 1,...,I;j = 1,...,J, k
= 1,...,K, satisfying a negative binomial distribution with
parameter(a,1, Pt,). Thevariablea denotes the shapeparameter
ofthehiddenredistributionandp = 0/1 + 0, where0 is scale
parameteroftheredistribution. Twocasesareconsideredforthe
seconddesign: a) only a,1 depends on the two factors (and0 is
independent ofA and B), b) only 0,j depends on two factors.
Caseacorrespondstoaconstantmean/varianceratiodependent
onthemean. Casebcanbeimbedded intoaGLIM only ifa is
knownbecauseotherwisethedistribution doesnotbelongtoan
exponentialfamily.
Conclusions
Biostatisticshasmadeimportantcontributionstoanunbiased
andefficientanalysisoftheAmesSalmonellaassay; anddespite
thevarietyofgenotoxicityassays, thismethodology seemstobe
applicableoradjustabletoaconsiderablenumberofgenotoxicity
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assays. Onehastoaccountforconsiderable variabilityoftheout-
comevariableofanassaybecauseoffactorsactingduringtheex-
perimental progress aswellasbecauseofconditionsvaryingbe-
tween experiments. Variability can be partially controlled by
statistical methods. This necessitates designs withnegative and
positivecontrolsanduseofreplicates. Otherwise, commonbio-
metric principles ofexperimental design apply togenotoxicity
assays. Thisincludes thecomprehensive, formalplanningofthe
whole investigation. Blind evaluation, referenceevaluation, and
principles ofrandomization should beestablished and repeated
assays shouldbeplannedatthebeginningofaninvestigation. Se-
quentialmethodology maybehelpfulandshouldbeexploredfur-
ther. Assays ofa planned investigation should be checked for
heterogeneityofdistributionoftheoutcomevalues(e.g., means
andvariances). Weightedmeans are showninthiscontribution
asanelementary methodforcombiningestimatesobtainedfrom
genotoxicity assays andprovide summary measures. They can
be applied stepwise in higher-orderdesigns. Statistical regres-
sion models may be applied to well designed factorial ex-
periments and to studies with multivariate covariables.
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